This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carcinoma in situ of cervix uteri, endocervix
CD2_INSITU_CERVIX_UTERI_ENDOCERVIX_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleonly females |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D06
- Name in latin
- Carcinoma in situ endocervicis (uteri)
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of cervix uteri, endocervix
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of cervix uteri, endocervix
- HSIL lesion of the cervix uteri
- HSIL lesion of the cervix uteri, vagina or vulva
- All dysplastic lesions of the cervix uteri
- All dysplastic lesions of the cervix uteri, vagina or vulva
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 438 | 438 | - |
| Unadjusted period prevalence (%) | 0.15 | 0.15 | - |
| Median age at first event (years) | 38.86 | 38.86 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 381
- Matched controls
- 3809
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D06.0
ICD-10 Finland
Carcinoma in situ: Endocervix
+∞
323.0
381
*
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
60.7
222.4
273
152
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
31.9
181.8
302
407
ULA02
NOMESCO Finland
Kolposcopy
31.4
180.6
299
396
8140/2-C53.9
ICD-O-3
Adenocarcinoma in situ, NOS, of cervix uteri
+∞
143.0
128
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
17.9
134.4
269
450
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
15.7
112.2
215
290
LDA10
NOMESCO Finland
Curettage of cervix uteri
17.3
94.0
161
154
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
24.2
85.8
126
76
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
34.8
75.8
99
38
8070/2-C53.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of cervix uteri
155.0
72.9
75
6
D06.1
ICD-10 Finland
Carcinoma in situ: Exocervix
191.6
63.1
64
*
C53.02
ICD-10 Finland
Adenocarcinoma of the endocervix
+∞
38.2
36
*
D06.9
ICD-10 Finland
Carcinoma in situ: Cervix, unspecified
327.0
30.3
30
*
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
9.2
29.1
63
80
8140/2-C53.0
ICD-O-3
Adenocarcinoma in situ, NOS, of endocervix
+∞
27.4
26
*
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
9.7
26.4
55
65
8140/2-C53.1
ICD-O-3
Adenocarcinoma in situ, NOS, of exocervix
+∞
26.4
25
*
8140/3-C53.9
ICD-O-3
Adenocarcinoma, NOS, of cervix uteri
+∞
25.3
24
*
LEB00
NOMESCO Finland
Biopsy of vagina
15.3
24.2
40
29
N87.1
ICD-10 Finland
Moderate cervical dysplasia
7.9
22.6
53
76
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
22.1
21
*
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
10.5
20.4
40
42
LBE20
NOMESCO Finland
Laparoscopic bilateral salpingectomy
8.6
20.0
44
57
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.7
19.3
217
1251
ZXC00
NOMESCO Finland
Use of diathermy
29.6
19.0
25
9
LCA06
NOMESCO Finland
Biopsy of endometrium
3.4
18.2
101
363
115
Kela drug reimbursment
Breast cancer
+∞
16.8
16
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
9.0
16.1
34
41
H02AB02
ATC
dexamethasone; systemic
16.6
15.9
25
16
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
62.8
15.9
18
*
C53.11
ICD-10 Finland
Squamous cell carcinoma and exocervix
+∞
15.7
15
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
15.7
15
*
LCD10
NOMESCO Finland
Vaginal hysterectomy
6.5
15.7
41
69
PJA12
NOMESCO Finland
Sentinel node biopsy
47.0
15.2
18
*
LDC00
NOMESCO Finland
Conisation of cervix uteri using knife
83.4
14.7
16
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
14.7
14
*
WX402
NOMESCO Finland
General anaesthesia
3.2
14.7
86
319
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
13.6
13
*
LCD31
NOMESCO Finland
Radical laparoscopic hysterectomy
+∞
13.6
13
*
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
20.9
12.6
18
9
C53.12
ICD-10 Finland
Adenocarcinoma of the exocervix
+∞
12.6
12
*
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
134.2
12.5
13
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
134.2
12.5
13
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.7
12.3
99
443
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
11.5
11
*
C53.01
ICD-10 Finland
Squamous cell carcinoma of the endocervix
+∞
11.5
11
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
11.5
11
*
B01AB10
ATC
tinzaparin; parenteral
5.7
11.3
32
60
ZXC96
NOMESCO Finland
Robot assisted procedure
18.5
10.8
16
9
N87.9
ICD-10 Finland
Dysplasia of cervix uteri, unspecified
22.2
10.8
15
7
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.5
10
*
8070/3-C53.9
ICD-O-3
Squamous cell carcinoma, NOS, of cervix uteri
+∞
10.5
10
*
130
Kela drug reimbursment
Malignant tumour
+∞
10.5
10
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
10.5
10
*
N87.0
ICD-10 Finland
Mild cervical dysplasia
4.7
10.3
35
81
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
7.0
10.1
24
36
B01AB05
ATC
enoxaparin; parenteral
2.3
9.9
105
538
C539, 6666, 0
ICD-O-3
NA
7.1
9.8
23
34
A63.0
ICD-10 Finland
Anogenital (venereal) warts
3.8
9.7
41
117
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
56.5
9.7
11
*
XX3DW
NOMESCO Finland
Time consuming IT work
4.5
9.6
33
78
8140/3-C53.0
ICD-O-3
Adenocarcinoma, NOS, of endocervix
+∞
9.4
9
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
9.4
9
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
9.4
9
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
16.1
9.1
14
9
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.1
8.8
49
171
HAC20
NOMESCO Finland
Total mastectomy
51.2
8.7
10
*
LDB20
NOMESCO Finland
Electrocoagulation or laser therapy of cervix uteri
7.0
8.5
20
30
C53.00
ICD-10 Finland
Malignant tumor of endocervix without histology
+∞
8.4
8
*
8076/3-C53.9
ICD-O-3
Squamous cell carcinoma, microinvasive of cervix uteri
+∞
8.4
8
*
LBE01
NOMESCO Finland
Laparoscopic salpingectomy
3.9
8.3
33
90
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
6.0
7.6
20
35
WF002
NOMESCO Finland
Radical radiotherapy
25.6
7.6
10
*
JN4BD
NOMESCO Finland
Extensive body CT
5.2
7.5
22
44
WF003
NOMESCO Finland
Adjuvant radiotherapy
81.6
7.4
8
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
81.6
7.4
8
*
L02BA01
ATC
tamoxifen; oral
81.6
7.4
8
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.3
7
*
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
4.9
6.8
21
45
LDB00
NOMESCO Finland
Excision of lesion of cervix uteri
8.9
6.6
13
15
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
71.0
6.4
7
*
G01AA10
ATC
clindamycin; vaginal
1.9
6.4
107
646
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
8010/2-C53.9
ICD-O-3
Carcinoma in situ, NOS, of cervix uteri
+∞
6.3
6
*
Z51.5
ICD-10 Finland
Palliative care
27.2
6.3
8
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.1
6.1
32
110
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
96
102
11.77
84.51
1.4
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
85
128
8.00
56.06
3.1
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
108
271
4.96
41.38
2.7
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
237
1236
3.00
28.19
2.6
1.5
—
—
—
0
0
(4281824)
26
20
13.76
27.35
1.0
1.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
261
1469
2.92
26.39
2.9
1.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
24
30
8.41
18.06
2.8
1.7
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
66
254
2.88
12.63
1.8
1.5
u/ml
21.4
28.0
0.56
61
245
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
232
1624
1.91
9.99
3.7
3.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
153
987
1.85
8.08
1.8
1.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
12
8
15.37
7.75
1.1
1.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
166
1139
1.74
6.90
3.5
3.9
g/l
36.8
37.2
0.48
153
1052
(3002256) Pathology report gross observation
68
349
2.12
6.87
1.3
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
52
251
2.22
6.12
2.1
2.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
58
301
2.07
5.68
3.4
3.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
232
1829
1.57
5.11
4.3
4.1
estimate
0.0
0.0
0.50
63
343
(3009261) Glucose [Presence] in Urine by Test strip
233
1850
1.55
4.89
3.2
3.0
estimate
0.0
0.0
0.50
62
333
(3021589) Normoblasts [#/volume] in Blood
200
1545
1.54
4.69
7.9
6.8
e9/l
0.0
0.0
0.00
172
1271
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
105
735
1.56
3.69
1.8
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
144
1091
1.48
3.47
3.2
2.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
390
3608
1.74
3.29
9.6
9.0
mmol/l
3.9
3.9
0.22
380
3494
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
180
1437
1.43
3.25
3.2
2.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
371
3406
1.58
3.02
9.0
7.1
ml/min/173m2
91.5
91.5
0.01
314
2716
(3019550) Sodium [Moles/volume] in Serum or Plasma
388
3602
1.68
3.00
9.6
9.0
mmol/l
139.6
139.6
0.06
379
3500
(3023368) Bacteria identified in Blood by Culture
77
527
1.56
2.96
3.1
3.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
35
193
1.88
2.94
3.1
2.1
mmol/l
1.2
1.2
0.56
28
158
(3030467) Casts [#/volume] in Urine by Automated count
106
784
1.46
2.83
2.5
2.4
e6/l
0.3
0.4
0.30
82
569
(3002582) Erythrocytes [#/volume] in Urine
115
871
1.43
2.70
2.5
2.5
e6/l
167.9
90.5
0.23
88
644
(3035350) Ketones [Presence] in Urine by Test strip
216
1827
1.36
2.60
3.1
2.9
estimate
0.0
0.0
0.50
62
340
(3013826) Glucose [Moles/volume] in Serum or Plasma
208
1750
1.36
2.58
3.4
4.0
mmol/l
6.4
6.3
0.31
199
1556
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
131
1023
1.40
2.58
2.7
2.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
147
1171
1.38
2.57
1.6
1.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
123
952
1.41
2.54
3.2
2.0
mmol/l
2.3
2.3
0.60
115
842
(3022096) Basophils/100 leukocytes in Blood
193
1608
1.36
2.54
6.0
5.5
%
0.7
0.7
0.10
188
1484
(3004588) Protein electrophoresis panel - Serum or Plasma
25
132
1.95
2.41
1.2
1.3
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
12
46
2.65
2.38
4.3
2.4
kpa
5.1
5.0
0.21
12
46
(3012501) Base excess in Blood by calculation
12
46
2.65
2.38
4.3
2.4
mmol/l
2.7
2.4
—
7
32
(3027315) Oxygen [Partial pressure] in Blood
12
46
2.65
2.38
4.3
2.4
kpa
9.4
9.2
0.13
12
46
(42870588) Differential panel, method unspecified - Blood
135
1075
1.37
2.33
5.7
5.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
118
927
1.37
2.21
3.3
3.2
estimate
0.0
0.0
0.80
63
344
(3007461) Platelets [#/volume] in Blood
433
4231
3.05
2.19
15.7
13.8
e9/l
269.5
269.0
0.05
426
4155
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
164
1360
1.33
2.14
5.4
5.2
mmol/l
1.2
1.2
0.34
128
1162
(3001604) Monocytes [#/volume] in Blood
209
1794
1.32
2.14
5.7
5.4
e9/l
0.5
0.5
0.28
191
1592
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
63
444
1.49
2.13
2.2
2.1
e6/l
1.4
1.0
0.61
40
229
(3006315) Basophils [#/volume] in Blood
210
1806
1.31
2.11
5.7
5.4
e9/l
0.0
0.0
0.31
191
1596
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
11
43
2.60
2.11
1.1
1.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
196
1670
1.31
2.11
6.1
5.4
%
2.7
2.7
0.08
191
1548
(3012565) Volume of 24 hour Urine
5
10
5.04
2.07
1.2
2.8
ml
1686.0
2428.0
—
5
10
(3013512) EKG study
93
710
1.39
2.06
2.6
2.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
114
903
1.35
2.01
4.1
5.2
inr
1.0
1.1
3.44
45
312
(3019069) Monocytes/100 leukocytes in Blood
196
1682
1.30
1.96
6.3
5.6
%
8.2
7.7
1.44
191
1571
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
394
3742
1.53
1.93
9.9
9.0
mg/l
21.6
17.2
1.82
314
2799
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
143
1181
1.31
1.89
4.9
4.7
mmol/l
1.2
1.2
0.33
124
1069
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
22
3.22
1.88
2.6
2.3
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
7
22
3.22
1.88
2.6
2.3
mmol/l
3.9
4.1
—
7
22
(3035285) Chloride [Moles/volume] in Venous blood
7
22
3.22
1.88
2.6
2.3
mmol/l
106.4
106.4
—
7
22
(3037467) Urinalysis macro (dipstick) panel - Urine
282
2550
1.30
1.84
3.8
3.7
—
—
—
0
0
(3015736) pH of Urine
169
1432
1.29
1.84
2.7
2.8
—
—
—
0
0
(3026782) Osmolality of Urine
74
556
1.40
1.80
2.7
2.2
mosm/kgh2o
548.1
533.3
0.23
64
466
(36304419) Bacteria [Presence] in Urine
100
791
1.34
1.77
2.5
2.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
19
103
1.88
1.74
2.8
9.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
214
1884
1.27
1.67
5.7
5.6
e9/l
0.2
0.2
0.33
194
1705
(3002030) Lymphocytes/100 leukocytes in Blood
200
1748
1.27
1.66
6.1
5.4
%
29.3
29.9
0.43
193
1625
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
409
3935
1.59
1.65
8.8
7.5
u/l
23.5
23.4
0.05
397
3831
(3018095) Leukocytes [#/volume] in Urine
136
1137
1.28
1.61
2.8
2.9
e6/l
198.2
62.3
0.76
98
710
(3013650) Neutrophils [#/volume] in Blood by Automated count
221
1959
1.26
1.61
8.7
6.4
e9/l
3.7
4.0
1.65
205
1723
(3018418) pH of Serum or Plasma
98
785
1.32
1.59
3.3
2.8
ph
7.4
7.4
0.32
26
133
(3018010) Neutrophils/100 leukocytes in Blood
198
1736
1.26
1.57
6.0
5.2
%
55.5
56.7
0.83
193
1620
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
21
2.88
1.51
1.0
1.1
miu/ml
1308.0
1707.9
—
6
21
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
13
65
2.03
1.50
3.5
2.2
mg/l
1.4
1.3
0.15
13
60
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
56
415
1.40
1.49
2.3
2.2
e6/l
5.3
4.4
0.18
33
199
(3019198) Lymphocytes [#/volume] in Blood
210
1862
1.25
1.49
5.8
5.4
e9/l
1.9
2.0
0.37
194
1690
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
60
452
1.38
1.45
2.4
1.7
mmol/l
2.4
2.4
0.63
53
384
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
171
1485
1.25
1.45
5.6
3.4
umol/l
8.7
9.7
1.12
166
1374
(1761482) Bacteria [#/volume] in Urine by Culture
12
59
2.06
1.45
3.3
2.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
20
118
1.73
1.44
3.9
6.6
mmol/l
24.5
24.4
0.04
20
118
(3003396) Base excess in Arterial blood by calculation
32
215
1.53
1.40
7.2
9.3
mmol/l
-0.0
0.8
0.53
25
162
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
29
2.44
1.39
1.0
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
30
435
0.67
1.34
1.7
1.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
17
99
1.75
1.29
10.3
14.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
19
297
0.62
1.21
1.2
1.6
mu/l
203.4
323.2
3.18
14
265
(3002179) Metamyelocytes/100 leukocytes in Blood
32
223
1.47
1.20
5.1
4.0
%
0.4
0.8
—
5
34
(3019225) pH of Specimen
35
249
1.44
1.19
3.6
3.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
59
465
1.31
1.10
1.3
1.3
iu/l
31.8
26.5
0.48
50
409
(3000850) Epithelial cells [#/volume] in Urine
75
613
1.27
1.06
2.2
2.2
e6/l
8.6
10.0
0.28
66
535
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
147
0.54
1.05
1.9
1.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
268
2492
1.19
1.03
7.1
5.0
u/l
69.5
70.9
0.33
255
2318
(3026389) Candida sp identified in Specimen by Organism specific culture
9
47
1.93
1.02
1.8
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
35
2.02
1.00
1.1
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
74
890
0.80
1.00
1.6
1.7
mmol/l
1.3
1.4
0.28
62
782
(3037756) Immunofixation for Serum or Plasma
0
29
0.00
0.98
0.0
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
31
0.00
0.96
0.0
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
27
372
0.71
0.96
1.1
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
24
336
0.70
0.93
1.7
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
32
236
1.38
0.93
5.9
4.2
%
0.4
1.0
—
5
43
(40768793) Breast Pathology biopsy report
10
55
1.84
0.93
1.0
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
10
55
1.84
0.93
1.0
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
17
110
1.57
0.92
1.1
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
71
1.71
0.89
2.5
4.2
%
53.4
57.4
0.60
12
71
(3030905) Polymorphonuclear cells [#/volume] in Blood
12
71
1.71
0.89
2.5
3.6
e9/l
3.3
4.2
1.27
12
71
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
43
1.88
0.87
2.4
2.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
172
1558
1.17
0.86
2.0
2.3
nmol/l
74.4
75.6
0.26
157
1450
(3009508) Creatinine [Moles/volume] in Urine
71
842
0.81
0.85
3.4
3.1
mmol/l
8.1
7.6
0.44
60
716
(3003327) Ova and parasites identified in Stool by Light microscopy
10
166
0.59
0.85
1.7
1.9
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
31
1.95
0.84
2.2
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
30
223
1.37
0.84
6.1
4.3
%
0.0
0.2
—
5
36
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
312
3265
0.85
0.84
3.7
3.9
—
—
—
0
0
(4027681)
6
32
1.89
0.82
1.0
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
343
3292
1.19
0.79
12.1
11.0
%
13.3
13.5
1.58
335
3231
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
15
98
1.55
0.79
3.9
2.6
mg/l
7.7
9.2
0.46
15
90
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
23
313
0.72
0.78
1.6
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
378
3663
1.23
0.78
10.9
10.1
%
39.0
39.7
1.09
313
3061
(3000330) Specific gravity of Urine by Test strip
21
149
1.43
0.77
4.3
2.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
23
312
0.72
0.77
1.6
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
23
311
0.73
0.76
1.6
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
23
311
0.73
0.76
1.6
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
30
228
1.34
0.75
6.2
4.3
%
0.0
0.1
—
5
41
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
24
2.10
0.74
1.0
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
309
3225
0.86
0.74
4.2
4.5
pmol/l
14.2
14.2
0.08
285
3058
(3014576) Chloride [Moles/volume] in Serum or Plasma
29
221
1.33
0.72
8.1
6.6
mmol/l
103.7
104.5
0.36
29
214
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
55
457
1.23
0.71
1.5
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
341
3524
0.85
0.67
3.3
3.5
mmol/l
5.6
5.6
0.18
320
3321
(3002032) Base excess in Venous blood by calculation
24
180
1.35
0.66
2.0
3.2
mmol/l
1.6
1.8
0.10
17
137
(3021447) Carbon dioxide [Partial pressure] in Venous blood
24
180
1.35
0.66
2.0
3.2
kpa
5.8
5.8
0.03
24
175
(40760892) CBC W Ordered Manual Differential panel - Blood
107
953
1.16
0.66
4.4
3.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
24
181
1.34
0.64
1.5
1.7
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
5
29
1.73
0.64
1.0
1.8
%
91.9
91.8
—
5
29
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
94
1057
0.86
0.63
1.3
1.3
u/ml
0.5
2.1
2.15
33
303
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
79
1.53
0.63
1.0
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
21
278
0.74
0.62
1.3
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
71
1.56
0.62
1.1
1.5
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
15
105
1.44
0.61
12.9
10.6
%
94.1
94.5
0.13
15
105
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
51
1.58
0.60
1.0
1.3
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
20
0.00
0.60
0.0
1.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
61
708
0.84
0.60
3.8
3.2
mg/l
29.7
408.6
1.37
39
434
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
131
1192
1.14
0.60
1.6
1.8
pmol/l
94.2
99.0
0.44
68
641
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
3.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
41
337
1.24
0.60
4.4
4.2
—
—
—
0
0
(3012544) pH of Venous blood
24
184
1.32
0.59
2.0
3.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
20
264
0.75
0.59
1.7
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
236
2231
1.13
0.58
2.7
2.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
53
1.52
0.58
6.1
1.9
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
23
0.00
0.58
0.0
2.7
—
9.7
—
0
15
(3037522) Nuclear Ab [Titer] in Serum
72
628
1.18
0.58
1.4
1.4
titre
473.7
542.0
0.10
19
138
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
35
1.72
0.58
1.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
20
262
0.75
0.56
1.7
1.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
89
0.56
0.56
1.8
2.0
%
12.5
13.3
—
5
89
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
94
841
1.15
0.55
1.9
1.9
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
21
272
0.76
0.55
1.7
1.5
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
20
151
1.34
0.55
3.5
2.2
u/l
41.4
38.5
0.32
20
141
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
12
82
1.48
0.55
1.1
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
38
1.59
0.54
1.0
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
62
1.46
0.53
1.1
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
39
1.55
0.53
1.0
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
47
551
0.84
0.53
1.6
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
17
225
0.75
0.52
1.5
1.3
miu/ml
206.1
228.8
—
9
117
(3016018) Differential panel - Cerebral spinal fluid
6
40
1.51
0.52
1.5
2.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
69
607
1.16
0.51
1.7
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
21
162
1.31
0.51
2.6
2.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
17
223
0.75
0.49
1.2
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
18
234
0.76
0.49
1.1
1.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
7
107
0.65
0.49
2.0
2.3
%
118.7
158.7
—
7
102
(3003740) Influenza virus B Ag [Presence] in Specimen
7
108
0.64
0.49
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
108
0.64
0.49
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
22
276
0.79
0.47
1.0
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
7
48
1.47
0.47
5.9
2.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
10
142
0.70
0.47
1.3
1.3
—
—
—
0
0
(4094501)
5
81
0.61
0.46
1.2
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
22
275
0.79
0.46
1.2
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
20
253
0.78
0.46
1.6
1.8
mg/l
3.0
2.9
0.04
14
160
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
103
940
1.13
0.46
2.0
2.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
31
256
1.23
0.46
2.4
2.3
g/l
10.5
10.4
0.04
31
241
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
41
350
1.19
0.44
2.6
3.4
%
29.5
31.9
0.79
29
256
(3013707) Erythrocyte sedimentation rate by Westergren method
281
2709
1.10
0.43
4.0
3.8
mm/h
10.1
9.4
0.37
264
2555
(3019832) Treponema pallidum Ab [Presence] in Serum
76
842
0.88
0.43
1.5
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
32
1.57
0.42
1.2
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
33
390
0.83
0.42
1.3
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
15
0.00
0.41
0.0
3.6
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.5
—
1.0
—
0
15
(40765089) Chromosome analysis panel - Blood by G-banded
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
15
0.00
0.41
0.0
2.9
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
0
17
0.00
0.40
0.0
3.2
—
52.3
—
0
10
(3020682) Albumin/Creatinine [Ratio] in Urine
66
735
0.88
0.40
4.7
3.8
mg/mmol
4.5
7.6
0.77
43
443
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
59
662
0.87
0.40
1.3
1.4
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
8
60
1.34
0.40
1.9
2.2
ug/l
117.1
162.0
—
8
49
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
18
0.00
0.40
0.0
1.7
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
18
0.00
0.40
0.0
1.7
—
9.9
—
0
18
(3019150) Specific gravity of Urine by Refractometry
71
786
0.88
0.40
2.7
3.1
kg/l
1.0
1.0
—
9
109
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
1.0
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
67
1.35
0.38
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
67
1.35
0.38
1.3
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
147
0.74
0.38
1.4
2.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
25
207
1.22
0.37
4.9
2.6
u/l
207.5
228.3
0.64
25
199
(1761868) Lipid panel - Serum or Plasma
167
1581
1.09
0.37
2.3
2.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
90
1.34
0.36
1.0
1.3
—
1.5
—
0
9
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
77
0.65
0.36
1.4
1.9
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
41
359
1.16
0.34
2.8
2.4
%
27.4
24.3
0.65
36
304
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
14
109
1.29
0.34
13.6
10.2
%
0.6
0.7
0.59
14
109
(46235355) HIV 1 and 2 tests - Meaningful Use set
130
1222
1.09
0.34
1.7
1.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
205
2135
0.93
0.33
2.9
2.9
ug/l
73.8
60.5
1.16
194
2032
(3004616) Nuclear Ab [Presence] in Serum
6
46
1.31
0.33
1.7
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
90
0.66
0.33
1.2
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
56
620
0.89
0.32
1.8
2.1
—
—
—
0
0
(4010399)
26
220
1.19
0.32
1.3
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
47
1.28
0.32
1.0
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
40
352
1.15
0.32
1.5
1.9
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
316
3233
0.92
0.31
4.1
4.3
mmol/mol
37.5
37.7
0.20
299
3069
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
49
545
0.89
0.31
1.5
1.5
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
54
1.30
0.30
1.6
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
84
1.32
0.30
1.0
1.3
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
23
194
1.20
0.30
1.1
1.3
—
0.8
—
0
17
(3022145) Colonoscopy Study observation
40
355
1.14
0.29
1.3
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
19
158
1.21
0.28
10.3
7.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
54
490
1.12
0.28
2.2
2.6
ng/l
639.0
695.8
0.06
43
399
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
12
94
1.28
0.28
1.9
2.2
%
1.5
1.2
0.26
12
94
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
88
822
1.09
0.27
1.4
1.3
iu/ml
24.8
25.6
0.03
34
285
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
66
1.22
0.27
1.3
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
12
95
1.27
0.26
1.3
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
405
4008
1.14
0.26
10.0
8.9
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
50
455
1.11
0.25
1.7
1.6
nmol/l
1217.0
1134.3
0.22
35
359
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
108
1142
0.93
0.25
1.5
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
40
444
0.89
0.25
1.3
1.2
iu/ml
167.2
146.5
—
8
191
(3050129) First trimester maternal screen panel - Serum or Plasma
32
360
0.88
0.25
1.4
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
16
190
0.84
0.24
1.8
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
362
3670
0.92
0.23
3.2
3.6
mmol/l
1.6
1.6
0.08
340
3501
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
95
1006
0.93
0.23
1.5
1.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
91
859
1.07
0.22
1.7
2.0
u/l
106.1
113.5
0.23
84
817
(3000492) Spirometry study
43
392
1.11
0.22
1.4
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
33
296
1.12
0.22
1.8
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
361
3657
0.93
0.21
4.8
5.1
mu/l
1.7
2.0
0.55
332
3492
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
11
0.00
0.21
0.0
3.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
11
0.00
0.21
0.0
3.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
10
0.00
0.21
0.0
2.5
—
1.2
—
0
10
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
10
0.00
0.21
0.0
3.9
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
12
0.00
0.21
0.0
2.3
—
45.6
—
0
12
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
6.0
—
0
12
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
43
1.16
0.21
1.2
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
13
108
1.21
0.20
14.1
10.2
%
1.8
1.4
0.64
13
108
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(4034850)
9
114
0.79
0.20
6.8
5.9
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
51
1.18
0.19
1.0
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
84
886
0.94
0.19
1.3
1.3
g/l
2.2
2.2
0.03
60
565
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
49
528
0.92
0.19
1.4
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
357
3525
1.07
0.19
3.0
3.2
mmol/l
1.2
1.2
0.33
335
3342
(3005082) Progesterone [Moles/volume] in Serum or Plasma
6
53
1.13
0.18
1.2
1.4
nmol/l
25.9
29.4
—
6
45
(3039162) Centromere protein B Ab [Units/volume] in Serum
7
59
1.19
0.18
1.0
1.4
—
30.1
—
0
5
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
19
216
0.87
0.18
1.4
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
82
863
0.94
0.18
1.9
2.0
mg/l
2.5
2.6
0.31
64
744
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
368
3719
0.93
0.17
3.4
3.8
mmol/l
3.0
2.9
0.60
345
3534
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
117
1217
0.95
0.17
3.1
2.6
u/l
27.7
26.6
0.17
108
1167
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
11
131
0.84
0.17
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
68
0.73
0.17
1.6
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
72
759
0.94
0.16
2.0
2.0
umol/l
292.6
4743.1
2.79
62
685
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
103
988
1.06
0.16
2.4
2.6
ng/l
22.0
19.5
0.12
37
428
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
272
2672
1.05
0.16
2.8
2.8
u/l
33.3
32.7
0.06
264
2559
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
21
187
1.13
0.16
1.2
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
69
654
1.07
0.16
1.4
1.4
nmol/l
18.6
22.2
1.46
59
586
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
76
0.79
0.15
1.3
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
27
296
0.91
0.15
1.4
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
26
236
1.11
0.15
1.3
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
9
82
1.10
0.15
1.1
2.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
129
0.85
0.15
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
86
0.81
0.14
1.0
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
45
480
0.93
0.14
1.9
2.9
ng/l
34.4
327.2
0.94
19
252
(3007853) Bacteria identified in Skin by Aerobe culture
40
373
1.08
0.14
1.4
1.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
8
99
0.80
0.13
1.3
1.2
—
111.7
—
0
12
(3000764) Benzodiazepines [Presence] in Urine
25
228
1.10
0.13
1.6
1.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
43
458
0.93
0.13
1.3
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
365
3682
0.95
0.13
3.3
3.6
mmol/l
4.9
4.9
0.57
346
3524
(3018677) aPTT in Platelet poor plasma by Coagulation assay
33
355
0.92
0.13
2.3
1.8
s
30.0
29.5
0.26
33
349
(3016879) Cocaine [Presence] in Urine
24
219
1.10
0.13
1.6
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
25
229
1.10
0.12
1.6
1.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
11
127
0.86
0.12
1.6
2.7
mmol/l
1.7
1.8
0.04
11
84
(40758558) Short blood count panel - Blood
80
832
0.95
0.12
6.4
4.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
83
862
0.95
0.12
1.7
1.7
mg/l
0.7
0.7
0.01
62
630
(3028300) Cannabinoids [Presence] in Urine
25
230
1.09
0.11
1.6
1.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
38
357
1.07
0.11
1.6
2.1
umol/l
3.7
4.4
1.29
26
300
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
102
988
1.04
0.11
2.3
2.2
u/l
48.8
55.2
2.09
96
914
(3026008) Bacteria identified in Urine by Culture
99
960
1.04
0.10
2.7
2.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
13
115
1.13
0.10
1.5
2.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
45
1.11
0.10
1.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
45
1.11
0.10
1.4
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
54
517
1.05
0.09
1.8
1.6
%
1.4
1.3
0.39
46
472
(3025941) Bacteria identified in Stool by Culture
27
252
1.08
0.09
1.3
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
5
47
1.06
0.09
1.2
1.2
nmol/l
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
11
124
0.88
0.09
1.0
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
13
144
0.90
0.08
1.2
1.1
—
7.2
—
0
27
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
59
612
0.96
0.08
1.6
1.6
pmol/l
440.1
37523197.5
1.05
47
549
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
10
113
0.88
0.08
1.1
1.2
—
34.3
—
0
11
(3027944) Amphetamines [Presence] in Urine
24
224
1.08
0.08
1.6
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
185
0.92
0.08
1.5
1.7
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
7
64
1.10
0.08
9.4
6.4
umol/l
323.9
384.5
—
7
54
(3020891) Body temperature
7
64
1.10
0.08
4.7
4.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
23
245
0.94
0.07
2.1
1.7
ml/min/173m2
80.0
79.0
—
8
92
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
82
0.85
0.07
1.4
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
122
0.90
0.07
1.0
1.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
8
91
0.88
0.07
2.5
2.5
g/l
3.8
3.7
—
8
85
(3021879) Hepatitis B virus core Ab [Presence] in Serum
32
334
0.95
0.05
1.5
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
18
192
0.93
0.05
1.6
1.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
16
149
1.08
0.05
1.7
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
16
171
0.93
0.05
2.4
1.6
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
31
298
1.04
0.04
4.2
5.1
mmol/l
1.0
1.0
0.84
31
278
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
14
131
1.07
0.03
1.1
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
62
608
1.02
0.03
1.2
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
24
231
1.04
0.03
1.3
1.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
11
118
0.93
0.03
1.1
1.1
u/ml
0.3
2.4
—
5
47
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
84
830
1.01
0.02
1.2
1.3
u/ml
9.1
11.8
0.13
36
355
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
13
123
1.06
0.01
1.0
1.2
—
2.8
—
0
18
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
38
372
1.02
0.01
2.0
2.1
u/l
1432.3
4302.9
0.95
15
153
(3022217) INR in Platelet poor plasma by Coagulation assay
23
223
1.03
0.01
6.7
12.3
inr
1.5
1.2
—
7
37
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
146
0.96
0.00
2.4
2.1
—
—
—
0
0
(1002224) Polysomnography panel
21
216
0.97
0.00
1.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
95
1.05
0.00
1.4
1.7
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
13
125
1.04
0.00
1.1
1.1
ug/l
2.2
2.6
0.43
13
115
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
104
0.96
0.00
1.6
1.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
24
236
1.02
0.00
3.2
2.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
22
223
0.99
0.00
2.9
3.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
10
102
0.98
0.00
1.0
1.1
u/ml
0.0
1.3
—
5
42
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
26
257
1.01
0.00
1.3
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
122
0.98
0.00
1.1
1.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
36
362
0.99
0.00
1.4
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
40
402
0.99
0.00
1.3
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
12
121
0.99
0.00
1.0
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
15
151
0.99
0.00
1.2
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
19
191
0.99
0.00
10.3
6.1
mmol/l
1.2
1.2
0.05
19
182
(3048689) Calprotectin [Mass/mass] in Stool
58
581
1.00
0.00
2.4
2.4
ug/g
124.6
83.5
0.74
42
451
(3000475) Leukocytes [#/volume] in Synovial fluid
5
54
0.93
0.00
3.0
1.8
e6/l
583.6
11481.1
—
5
43
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
9
0.00
0.00
0.0
1.6
—
1.2
—
0
9
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
54
0.93
0.00
1.2
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
60
1.00
0.00
1.7
1.5
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
2.8
—
7.8
—
0
5
(3052851) Hemolysis interference index of Serum or Plasma
7
74
0.95
0.00
3.3
3.4
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
7
0.00
0.00
0.0
3.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
80
1.00
0.00
1.4
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
62
0.97
0.00
1.3
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
87
0.92
0.00
3.0
1.6
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
8
88
0.91
0.00
1.4
1.6
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
79
1.01
0.00
1.3
1.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
1.5
—
0
7
(44806420)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
52
0.96
0.00
1.2
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
5
57
0.88
0.00
1.4
2.0
ug/l
0.1
1.3
—
5
52
(3014271) Vancomycin [Susceptibility]
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
80
800
1.00
0.00
2.8
2.9
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
4.8
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
8
0.00
0.00
0.0
11.0
—
26.5
—
0
8
(44806071)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
4.0
—
357.3
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_CERVIX_UTERI_ENDOCERVIX_EXALLC – Carcinoma in situ of cervix uteri, endocervix
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).